跳转至内容
Merck
CN

90899

Supelco

大麻二酚标准液 溶液

~10 mg/mL in ethanol, analytical standard, for drug analysis

别名:

CBD

登录查看公司和协议定价

关于此项目

经验公式（希尔记法）:
C21H30O2
CAS Number:
13956-29-1
分子量:
314.46
EC 号:
200-578-6
MDL编号:
MFCD00869597
UNSPSC代码:
41116107
PubChem化学物质编号:
329769963
NACRES:
NA.24

主要文件

查看所有文档
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

质量水平

100

方案

≥98.5% (HPLC)

保质期

limited shelf life, expiry date on the label

药品控制

USDEA Schedule I; regulated under CDSA - not available from Sigma-Aldrich Canada

浓度

~10 mg/mL in ethanol

技术

HPLC: suitable
gas chromatography (GC): suitable

适用性

corresponds for H-NMR

应用

pharmaceutical (small molecule)

包装形式

single component solution

储存温度

2-8°C

SMILES字符串

CCCCCc1cc(O)c([C@@H]2C=C(C)CC[C@H]2C(C)=C)c(O)c1

InChI

1S/C21H30O2/c1-5-6-7-8-16-12-19(22)21(20(23)13-16)18-11-15(4)9-10-17(18)14(2)3/h11-13,17-18,22-23H,2,5-10H2,1,3-4H3/t17-,18+/m0/s1

InChI key

QHMBSVQNZZTUGM-ZWKOTPCHSA-N

基因信息

human ... CNR1(1268)

正在寻找类似产品? 访问 产品对比指南

一般描述

通过研究大麻二酚的免疫抑制机制，可以将其用于免疫相关疾病的研究。

应用

有关合适的仪器技术的更多信息，请参阅产品′的分析证书。联系技术服务部以获得进一步支持。

包装

安瓿包含 1.2mL 溶液

象形图

FlameExclamation mark
GHS02,GHS07

警示用语：

Danger

危险声明

H225,H319

危险分类

Eye Irrit. 2 - Flam. Liq. 2

储存分类代码

3 - Flammable liquids

WGK

WGK 2

闪点(°F)

57.2 °F - closed cup

闪点(°C)

14 °C - closed cup

个人防护装备

Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter

法规信息

监管及禁止进口产品

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
BCCL7243
BCCK1493
BCCG3988
BCCD7054
BCCC4006

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Cannabidiol (CBD) induces functional Tregs in response to low-level T cell activation
Dhital S, et al.
Cellular Immunology, 312, 25-34 (2017)
Bruno Gavinho et al.
Frontiers in cellular and infection microbiology, 10, 417-417 (2020-10-20)
Giardia intestinalis is a microaerophilic protozoan that is an important etiologic agent of diarrhea worldwide. There is evidence that under diverse conditions, the parasite is capable of shedding extracellular vesicles (EVs) which modulate the physiopathology of giardiasis. Here we describe
Javier Fernández-Ruiz et al.
British journal of clinical pharmacology, 75(2), 323-333 (2012-05-26)
Cannabidiol (CBD) is a phytocannabinoid with therapeutic properties for numerous disorders exerted through molecular mechanisms that are yet to be completely identified. CBD acts in some experimental models as an anti-inflammatory, anticonvulsant, anti-oxidant, anti-emetic, anxiolytic and antipsychotic agent, and is
Amir Englund et al.
Journal of psychopharmacology (Oxford, England), 27(1), 19-27 (2012-10-09)
Community-based studies suggest that cannabis products that are high in Δ⁹-tetrahydrocannabinol (THC) but low in cannabidiol (CBD) are particularly hazardous for mental health. Laboratory-based studies are ideal for clarifying this issue because THC and CBD can be administered in pure
Marcos Hortes N Chagas et al.
Journal of psychopharmacology (Oxford, England), 27(3), 312-316 (2013-01-25)
Cannabidiol (CBD) is one of the main components of Cannabis sativa and has a wide spectrum of action, including effects in the sleep-wake cycle. The objective of this paper is to assess the effects on sleep of acute systemic administration
查看所有相关文献

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持